account_name,fit,urgency,total,fit_reason,urgency_reason,urgency_source,trigger_summary,sec_matched_total,sec_examples,patent_matched_total,patent_examples,target_roles
AstraZeneca,5.0,3.0,22.1,CAR-T trial,RECRUITING in high urgency phase (PHASE1),clinicaltrials,"trial_candidate: A Study of AZD0120 in Autoimmune Diseases | trial_candidate: A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subje | sec_filing: 6-K filed 2026-02-10 â€“ FINAL RESULTS",0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
Pfizer,4.0,3.0,20.1,molecule match: elranatamab,RECRUITING in high urgency phase (PHASE1),clinicaltrials,"trial_candidate: A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients  | trial_candidate: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) | trial_candidate: A Study to Learn About Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With D",0,[],0,[],"[""Clinical Scientist / Early Clinical Development Lead (Phase 1)"", ""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development""]"
GSK,1.0,0.0,4.0,no trials,no trials and no relevant sec/patent signals,none,,0,[],0,[],"[""Director/VP, Translational Medicine (Oncology/Immunology)"", ""Head/Director, Clinical Biomarkers / Translational Biomarkers"", ""Head/Director, Immune Monitoring / Flow Cytometry / Cytometry Core"", ""Director, Bioassay / Potency / Analytical Development"", ""Clinical Scientist / Early Clinical Development Lead (Phase 1)""]"
